Clinical trial

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

NCT07263490

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-10-21

PhaseN/A

Study timeline

Study start (actual)2024-10-21Date precision: day

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pre-eclampsiaunresolved

Oocyte Donationunresolved

Pre-Eclampsia; Complicating Pregnancyunresolved

Pre-Eclampsia; Mildunresolved

Pre-Eclampsia, Severeunresolved

Pre-eclampsia or Eclampsia With Pre-existing Hypertensionunresolved

ARTunresolved

Neonatal Morbidityunresolved

Neonatal Mortalityunresolved

Placental Abruptionunresolved

Gestational Diabetesunresolved

Preterm Laborunresolved

Post-partum Hemorrhage (PPH)unresolved

Intrauterine Growth Restriction (IUGR)unresolved

Hypertensive Disorders of Pregnancyunresolved

Interventions

Sponsors & collaborators

Copenhagen University Hospital, Hvidovrelead sponsor

Ferring Pharmaceuticalscollaborator

Gedeon Richter Ltd.collaborator

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07263490 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.